Page 18 - Read Online
P. 18

Guerra et al. J Transl Genet Genom 2022;6:304-21  https://dx.doi.org/10.20517/jtgg.2022.08  Page 312



 Drug  Properties                      Pharmacogenetics
 Name: Capsaicin                       Pathogenic genes: DBH, MPO, BCHE, TACR2
 IUPAC name: 6-Nonenamide, (E)-N-[(4-hydroxy-3-methoxy-phenyl)   Mechanistic genes: TRPV1, PHB2, ABCB1, ACOX1, ACSL3,
 methyl]-8-methyl.                     ALOX5, CFTR, F2, FOS, HTR1D, NOS3, NPC1, PPARA, TAC1,
 Molecular Formula: C H NO .           TGFB1, UCP2
 18  27  3
 Molecular Weight: 305.41 g/mol        Metabolic genes:
 Mechanism: Induces release of substance P (main chemomediator of pain impulses from the periphery)   Substrate: GLU, CYP2E1 (minor), UGT1A1, UGT1A7, UGT1A9,
 from peripheral sensory neurons, depletes the neuron of substance   UGT1A10, GSTP1
 P (after repeated stimulation), and prevents reaccumulation.    Inhibitor: CYP3A4 (strong), CYP2C9, CYP2D6 (weak), PTGS2,
 Effect: Skin and Mucous Membrane Agents, local anesthetics, topical  MPO, CYP1A2 (strong), CYP1A2 (strong), CYP19A2 (strong),
                                       CYP2E1, DBH, BCHE
                                       Inductor: CYP1A1, CYP1A2
                                       Transporter genes: ABCB1
                                       Pleiotropic genes: TNF

 Name: Piperine                        Mechanistic genes: TRPV1, TRPA1, NR1I2, FOS
 IUAC name: (2E,4E)-5-(2H-1,3-Benzodioxol-5-yl)-1-(piperidin-1-yl)penta-2,4-dien-1-one.   Metabolic genes:
 Molecular Formula: C H NO             Substrate: CYP1A1
 3
 17
 19
 Molecular Weight: 285.34 g/mol        Inhibitor: CYP3A4, CYP2C9, CYP2D6 (weak)
 Mechanism: An alkaloid isolated from the plant Piper nigrum that has a role as an NF-kappaB inhibitor, a plant   Transporter genes: ABCB1 (inhibitor)
 metabolite, a food component, and a human blood serum metabolite. It is a member of benzodioxoles, an N-  Pleiotropic genes: TNF, IL1B, IL6
 acylpiperidine, a piperidine alkaloid, and a tertiary carboxamide.
 Effect: Skin and mucous membrane agents, local anesthetics, topical
 Name: Menthol                         Mechanistic genes: TRPM8, TOP1, FOS
 IUPAC name: (1R,2S,5R)-2-isopropyl-5-methylcyclohexanol   Metabolic genes:
 Molecular Formula: C H O              Substrate: CYP2A6
 10  20
 Molecular Weight: 156.26 g/mol
 Mechanism: A local anesthetic with counterirritant qualities, widely used to relieve minor throat irritation. Menthol also
 acts as a weak κ-opioid receptor agonist.
 Effect: Skin and mucous membrane agents, local anesthetics, topical
 Name: Imidapril                       Mechanistic genes: ACE, AGT, AGTR1, BDKRB2, CES1, CES2,
 IUPAC name: (4S)-3-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-1-methyl-2-  NOS3
 oxoimidazolidine-4-carboxylic acid;hydrochloride
 Molecular Formula: C H N O
 2
 6
 27
 3
 Molecular weight: 405,44 g/mol
 Mechanism: Prevents conversion of angiotensin I to angiotensin II, a potent vasoconstrictor.
 Effect: Angiotensin-converting enzyme inhibitors
 Name: Lisinopril                      Mechanistic genes: ACE, ACE2, REN, AGT; BDKRB2, MMP3,
 IUPAC name: L-Proline, 1-[N 2-(1-carboxy-3-phenylpropyl)-L-   NOS3, NPPA
 lysyl]-, dihydrate, (S)               Metabolic genes:
 Molecular Formula: C H N O H O        Substate: CYP3A4/5 (major)
 21  31  3  52  2
 Molecular Weight: 441.52 g/mol
 Mechanism: Competitive inhibitor of angiotensin-converting enzyme (ACE). Prevents conversion of angiotensin I to
 angiotensin II, a potent vasoconstrictor.
 Effect: Angiotensin-converting enzyme inhibitors
   13   14   15   16   17   18   19   20   21   22   23